Cargando…
Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats
The novel histone deacetylase inhibitor CG200745 was initially developed to treat various hematological and solid cancers. We investigated the molecular mechanisms associated with the renoprotective effects of CG200745 using deoxycorticosterone acetate (DOCA)-salt hypertensive (DSH) rats. DOCA strip...
Autores principales: | Bae, Eun Hui, Kim, In Jin, Song, Ji Hong, Choi, Hong Sang, Kim, Chang Seong, Eom, Gwang Hyeon, Kim, Inkyeom, Cha, Hyunju, Cho, Joong Myung, Ma, Seong Kwon, Kim, Soo Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387176/ https://www.ncbi.nlm.nih.gov/pubmed/30691015 http://dx.doi.org/10.3390/ijms20030508 |
Ejemplares similares
-
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
por: Choi, Hong Sang, et al.
Publicado: (2018) -
Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016) -
CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome
por: Suh, Sang Heon, et al.
Publicado: (2020) -
A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
por: Lee, Hee Seung, et al.
Publicado: (2017) -
Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production
por: Yoon, Ga-Eun, et al.
Publicado: (2019)